თამბაქოს მოწევის გავლენა რევმატიული დაავადებების მიმდინარეობაზე
DOI:
https://doi.org/10.52340/jecm.2025.06.18საკვანძო სიტყვები:
Rheumatic Diseases, Smoking, Autoimmune Diseases, Severity, Progressionანოტაცია
რევმატიული დაავადებების გავრცელება მსოფლიო მასშტაბით მზარდი ტენდენციით ხასიათდება. თამბაქოს მოწევა წარმოადგენს მნიშვნელოვან რისკ-ფაქტორს, რომელიც კავშირშია დაავადების მიმდინარეობასა და პროგრესთან. 2025 წელს ქ. ბათუმში კლინიკა „სოლომედში’’ ჩვენს მიერ შედგენილი კითხვარით ჩატარებულ კვლევაში მონაწილეობდა 131 პაციენტი სხვადასხვა ტიპის რევმატიული დაავადებით. კვლევამ აჩვენა, რომ აქტიურ მწეველებს ახასიათებდათ დაავადების მძიმე მიმდინარეობა, პასიურ მწეველებს – საშუალო სიმძიმის, ხოლო არამწეველებს – შედარებით მსუბუქი მიმდინარეობა. ასევე, დადასტურდა, რომ მოწევის შეწყვეტა ხელს უწყობდა დაავადების სიმპტომების შემცირებას და ზოგადი მდგომარეობის გაუმჯობესებას. თამბაქოს მოხმარების კონტროლი და პრევენცია, მნიშვნელოვანია რევმატიული დაავადებების მართვისა და პროგნოზის გაუმჯობესების თვალსაზრისით.
Downloads
წყაროები
World Health Organization. (2023, July 31). Tobacco. Retrieved from: https://www.who.int/news-room/fact-sheets/detail/tobacco
Influence of Smoking on Disease Activity and Quality of Life in Patients With Rheumatoid Arthritis: Results From a Swedish Case-Control Study With Longitudinal Follow-Up (2023 June), https://pubmed.ncbi.nlm.nih.gov/36149365/
GLOBAL ACTION TO END SMOKING. (2024, September 18). STATE OF SMOKING AND HEALTH IN GEORGIA. Retrieved from: https://globalactiontoendsmoking.org/research/tobacco-around-the-world/georgia/
Dai, X., Gil, G.F., Reitsma, M.B. et al. Health effects associated with smoking: a Burden of Proof study. Nat Med 28, 2045–2055 (2022). https://doi.org/10.1038/s41591-022-01978-x
Ishikawa Y, Terao C. The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review. Cells. 2020 Feb 19;9(2):475. doi: 10.3390/cells9020475. PMID: 32092988; PMCID: PMC7072747. https://pubmed.ncbi.nlm.nih.gov/32092988/
G. Westhoff, R. Rau, A. Zink, Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group, Rheumatology, Volume 47, Issue 6, June 2008, Pages 849–854, https://doi.org/10.1093/rheumatology/ken057
Sparks JA, Karlson EW. The Roles of Cigarette Smoking and the Lung in the Transitions Between Phases of Preclinical Rheumatoid Arthritis. Curr Rheumatol Rep. 2016 Mar;18(3):15. doi: 10.1007/s11926-016-0563-2. PMID: 26951253; PMCID: PMC4941234.
Sugiyama D, Nishimura K, Tamaki K, et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Annals of the Rheumatic Diseases. 2010 Jan;69(1):70-81. DOI: 10.1136/ard.2008.096487. PMID: 19174392.
Baka Z, Buzás E, Nagy G. Rheumatoid arthritis and smoking: putting the pieces together. Arthritis Res Ther. 2009;11(4):238. doi: 10.1186/ar2751. Epub 2009 Aug 3. PMID: 19678909; PMCID: PMC2745780.
Ren J, Ding Y, Zhao J, Sun Y. Impact of cigarette smoking on rheumatoid arthritis-associated lung diseases: a retrospective case control study on clinical and radiological features and prognosis. Rheumatol Int. 2023 Feb;43(2):293-301. doi: 10.1007/s00296-022-05219-9. Epub 2022 Sep 27. PMID: 36166058;
Adachi M, Okamoto S, Chujyo S, et al. Cigarette smoke condensate extracts induce IL-1-beta production from rheumatoid arthritis patient-derived synoviocytes, but not osteoarthritis patient-derived synoviocytes, through aryl hydrocarbon receptor-dependent NF-kappa-B activation and novel NF-kappa-B sites. J Interferon Cytokine Res. 2013 Jun;33(6):297-307. doi: 10.1089/jir.2012.0107. Epub 2013 Mar 1. PMID: 23452206.
Chang, K., Yang, S., Kim, S., Han, K., Park, S., & Shin, J. (2014). Smoking and Rheumatoid Arthritis. International Journal of Molecular Sciences, 15(12), 22279–22295. https://doi.org/10.3390/ijms151222279
Bartok, B., & Firestein, G. S. (2009). Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis. Immunological Reviews, 233(1), 233–255. https://doi.org/10.1111/j.0105-2896.2009.00859.x
Engler A, Niederer F, Klein K, Gay RE, Kyburz D, Camici GG, Gay S, Ospelt C. SIRT6 regulates the cigarette smoke-induced signalling in rheumatoid arthritis synovial fibroblasts. J Mol Med (Berl). 2014 Jul;92(7):757-67. doi: 10.1007/s00109-014-1139-0. Epub 2014 Mar 19. PMID: 24638860.
Poniewierska-Baran, A., Bochniak, O., et al. (2023). Role of sirtuins in the pathogenesis of rheumatoid arthritis. International Journal of Molecular Sciences, 24(2), 1532. https://doi.org/10.3390/ijms24021532
Chang K, Yang SM, Kim SH, Han KH, Park SJ, Shin JI. Smoking and rheumatoid arthritis. Int J Mol Sci. 2014 Dec 3;15(12):22279-95. doi: 10.3390/ijms151222279. https://pmc.ncbi.nlm.nih.gov/articles/PMC4284707/
The Eastern European & Central Asian Regional Audit, Epidemiology, costs & burden of osteoporosis in 2010 https://www.osteoporosis.foundation/sites/iofbonehealth/files/2019-06/2010_Eastern_European_Central_Asian_Audit_English.pdf
Yoon V, Maalouf NM, Sakhaee K. The effects of smoking on bone metabolism. Osteoporos Int. 2012 Aug;23(8):2081-92. doi: 10.1007/s00198-012-1940-y. Epub 2012 Feb 21. PMID: 22349964.
Dorian Parisis, Charlie Bernier, François Chasset, Laurent Arnaud, Impact of tobacco smoking upon disease risk, activity and therapeutic response in systemic lupus erythematosus: A systematic review and meta-analysis, Autoimmunity Reviews, Volume 18, Issue 11, 2019, 102393, ISSN 1568-9972, https://doi.org/10.1016/j.autrev.2019.102393.
Voss, M., et al. (2019). The effect of smoking on systemic lupus erythematosus disease activity. Lupus, 28(3), 274-280. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885243/
Farouk, H.M., Abdel-Rahman, M.A. & Hassan, R.M. Relationship between smoking, clinical, inflammatory, and radiographic parameters in patients with ankylosing spondylitis. Egypt Rheumatol Rehabil 48, 26 (2021). https://doi.org/10.1186/s43166-021-00076-z
Chung HY, Machado P, van der Heijde D, D'Agostino MA, Dougados M. Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort. Ann Rheum Dis. 2012 Jun;71(6):809-16. doi: 10.1136/annrheumdis-2011-200180. Epub 2011 Oct 11. PMID: 21989541.
Akar S, Kaplan YC, Ecemiş S, Keskin-Arslan E, Gercik Ö, Gücenmez S, Solmaz D. The role of smoking in the development and progression of structural damage in axial SpA patients: A systematic review and meta-analysis. Eur J Rheumatol. 2018 Oct 1;6(4):184-192. doi: 10.5152/eurjrheum.2019.19073. PMID: 3165770
Ciurea, Adrian, Almut Scherer, Ulrich Weber, Pascale Exer, Jürg Bernhard, et al. “Impaired Response to Treatment with Tumour Necrosis Factor α Inhibitors in Smokers with Axial Spondyloarthritis.” Annals of the Rheumatic Diseases 75, no. 3 (2016): 532–39. https://doi.org/10.1136/annrheumdis-2013-205133.
Zhao S, Challoner B, Khattak M, Moots RJ, Goodson NJ. Increasing smoking intensity is associated with increased disease activity in axial spondyloarthritis. Rheumatol Int. 2017 Feb;37(2):239-244. doi: 10.1007/s00296-016-3590-4. Epub 2016 Nov 4. PMID: 27815702; PMCID: PMC5258786.
Sublette MG, Cross TL, Korcarz CE, Hansen KM et al. Effects of Smoking and Smoking Cessation on the Intestinal Microbiota. J Clin Med. 2020 Sep 14;9(9):2963. doi: 10.3390/jcm9092963. PMID: 32937839
Ruiz-Esquide, V., & Sanmartí, R. (2012). Tobacco and other environmental risk factors in rheumatoid arthritis. Reumatología Clínica (English Edition), 8(6), 342–350. https://doi.org/10.1016/j.reumae.2012.06.007
Shen, F., Duan, Z., Li, S. et al. Factors associated with a better treatment efficacy among psoriasis patients: a study based on decision tree model and logistic regression in Shanghai, China. BMC Public Health 24, 1934 (2024). https://doi.org/10.1186/s12889-024-19468-9
Zhou H, Wu R, Kong Y, Zhao M, Su Y. Impact of smoking on psoriasis risk and treatment efficacy: a meta-analysis. J Int Med Res. 2020;48(10):300060520964024.
Pezzolo E, Naldi L. The relationship between smoking, psoriasis and psoriatic arthritis. Expert Rev Clin Immunol. 2019;15(1):41–8.
